• 69.5k views

Insulin Intensification in Management of T2DM

This webinar will cover “Insulin intensification in management of T2DM”. Will explore the discovery of insulin, evaluate the early experiences with insulin and assess the insulin innovation and real world experience. Insulin became the biggest contribution in the area of medical research, which completely transformed the treatment of diabetes by saving millions of lives worldwide. The primary goal of insulin intensification within the primary care setting is to minimize patients exposure to chronic hyperglycemia, weight gain and reduce patients risk of hypoglycemia, while achieving individualized fasting postprandial and A1C targets. Patients with type 2 diabetes need insulin therapy if other treatments haven't been able to keep the blood glucose level within required range and it prevents from other diabetes complications.

About the Speaker

Dr. MAGDY M ALLAM Profile Image

Dr. MAGDY M ALLAM

LECTURER of Internal medicine &Endocrinology AUSH Consultant Endocrinologist, Zulekha Hospital, Dubai Fellow of John Hopkins university Member of European Society of Endocrinology Member of Egyptian Society of Endocrinology & Obesity

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. MAGDY M ALLAM's Talks on Assimilate

webinar
Dr. MAGDY M ALLAM
  • 0

This webinar will cover “Insulin intensification in management of T2DM”. Will explore the discovery of insulin, evaluate the early experiences with insulin and assess the insulin innovation and real world experience. Insulin became the biggest contribution in the area of medical research, which completely transformed the treatment of diabetes by saving millions of lives worldwide. The primary goal of insulin intensification within the primary care setting is to minimize patients exposure to chronic hyperglycemia, weight gain and reduce patients risk of hypoglycemia, while achieving individualized fasting postprandial and A1C targets. Patients with type 2 diabetes need insulin therapy if other treatments haven't been able to keep the blood glucose level within required range and it prevents from other diabetes complications.